Page 107 - Recognizing axial spondyloarthritis - Janneke de Winter

from the Spondyloarthritis Caught Early (SPACE) cohort. Rheumatology (Oxford) 2013;52:1492–9.
15. Schöfl G, Lang K, Quenzel P, Böhme I, Sauter J, Hofmann JA, et al. 2.7 million samples genotyped for HLA by next generation sequencing: lessons learned. BMC Genomics 2017;18:161.
16. Reveille JD, Sims A-M, Danoy P, Evans DM, Leo P, Pointon JJ, et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010;42:123–7.
17. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007;39:1329– 37.
18. Costantino F, Talpin A, Chaplais E, Said-Nahal R, Leboime A, Zinovieva E, et al. A family-based genome- wide association study reveals an association of spondyloarthritis with MAPK14. Ann Rheum Dis 2015;74:148.
19. Tsui FW, Tsui HW, Akram A, Haroon N, Inman RD. The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis. Appl Clin Genet 2014;7:105–15.
20. Evans DM, Spencer CCA, Pointon JJ, Su Z, Harvey D, Kochan G, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011;43:761–767.
21. Cortes A, Pulit SL, Leo PJ, Pointon JJ, Robinson PC, Weisman MH, et al. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nat Commun 2015;6:7146.
22. Łuszczek W, Man M, Cisło M, Nockowski P, Wis A, Jasek M, et al. Gene for the Activating Natural Killer Cell Receptor , KIR2DS1 , is Associated With Susceptibility to Psoriasis Vulgaris. 2004;1.
23. Hundhausen C, Bertoni A, Mak RK, Botti E, Meglio P Di, Clop A, et al. Allele-specific cytokine responses at the HLA-C locus: implications for psoriasis. J Invest Dermatol 2012;132:635–41.
24. Kim K, Bang S-Y, Lee S, Lee H-S, Shim S-C, Kang YM, et al. An HLA-C amino-acid variant in addition to HLA-B*27 confers risk for ankylosing spondylitis in the Korean population. Arthritis Res Ther 2015;17:342.
25. Haroon M, Winchester R, Giles JT, Heffernan E, FitzGerald O. Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype. Ann Rheum Dis 2016;75:155–162.
26. Castro-Santos P, Moro-García MA, Marcos-Fernández R, Alonso-Arias R, Díaz-Peña R. ERAP1 and HLA-C interaction in inflammatory bowel disease in the Spanish population. Innate Immun 2017;23:476–481.
27. Boyton RJ, Altmann DM. Natural killer cells, killer immunoglobulin- like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol 2007;149:1–8.
HLA-C*07 IN AXIAL SPA
105
SIX